Although IL-6 levels have long been established as predictive of outcome in many infections,10 the most compelling evidence of a causal link between IL-6 and outcomes is depicted in severe COVID-19, where Mendelian randomisation studies identified a protective effect of reduced IL-6 signalling11 before this was confirmed by randomised trials.12 This evidence concerns the gene IL6 and COVID-19.